2023年5月9日

Genemod——一個基於雲的工作區為生物製藥研發團隊協作軟件,宣布獲得450萬美元的種子資金共同挑戰。vc和LDV夥伴參與杜比家庭企業和火神/目的地是合資企業。在過去的一年中,Genemod已經擴大到生物製藥研發空間與團隊從創業企業公司合作包括阿斯利康,百時美施貴寶,默克等等。在孤立的電子表格和工作,實時更新數據,在不同的地理位置和合作項目隻是幾個例子的團隊如何使用Genemod能夠消除無用功和其他壁壘,因此它們可以集中於生物製藥的發展。遺留研發軟件和其他傳統方法是分散的、無組織的,且效率低下,導致更高的醫療成本。和Genemod正在解決這個問題通過構建一個動態的基於雲計算的研究平台為研究小組設計的房子整個研發生命周期:從數據采集和項目文檔到庫存管理和報告。直觀的界麵使用戶能夠輕鬆可視化數據和跟蹤進度並更新變化是由誰——包括什麼。Genemod以努力解決再現性危機——這是一個持續的現象繼續擺脫研究科學家。再現性本質上是能夠重建相同的實驗實現相同的結果。雖然在理論上這可能聽起來簡單,雜亂的數據和長期缺乏基於雲的組織工具(在其他問題)意味著實驗結果仍是不一致的,美國政府花費和研究人員每年數十億。發現和臨床翻譯不再是由孤立的一次性實驗但複合加速收益規模的數據,再現性實驗和忠誠。 The COVID-19 pandemic played a major role in accelerating Genemod’s innovation and development with Genemod playing an important role in aiding pandemic-related research. And the pandemic overall led to collaboration between an increasing number of companies and research teams in a variety of industries. This includes the pharmaceutical and biotech business, which are leaning into dynamic, market-driven solutions in order to meet ever-increasing global healthcare and environmental challenges. KEY QUOTES: “We believe that scientists must be empowered with tools to discover and develop medicines and ultimately get them to market faster than ever before. That’s why we built Genemod – to transform the way biopharma companies operate.” — Jacob Lee, CEO and Co-founder of Genemod “Genemod aims to be the go-to standard for research scientists just as how designers use Figma and engineers use Jira.” — Jin Choe, Co-founder at Genemod “Biotechnology is one of the fastest growing industries in existence, and the software that powers efficiency and communication in labs has the potential to radically transform the world. Genemod is positioned to solve some of the world’s most pressing problems in the coming decades, from pandemics and other diseases to climate change. We are pleased to be investing in this great team and company and look forward to partnering with them as they continue to scale and grow.” — Neil Sequeira, Founder and Partner at defy.vc Trending on Pulse 2.0